Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0001209191-21-023576

CMO, SVP & Head of Drug Devt. acquired 38,655 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shetzline Michael · CMO, SVP & Head of Drug Devt.

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-26 Grant or award : show line 1 in the form +38,655 199,514 D
Loading xslF345X03/doc4.xml…